Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME (RMSM ICOD STUDY)

NCT04038125 is registered in ClinicalTrials.gov with Retina Macula Specialists of Miami, LLC as lead sponsor.

NCT NCT04038125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04038125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME (RMSM ICOD STUDY)
Lead sponsor
Retina Macula Specialists of Miami, LLC
Phase
Phase 4
Overall status
Unknown status
Start date
August 22, 2019
Completion date
August 31, 2021
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, diabetic retinopathy, retinal ischemia